TABLE 4.

Thirty-Day Clinical Follow-Up (N = 5)

Clinical outcomes
Any mortality	0
Cardiovascular mortality	0
Stroke or TIA	1 (20)
Reintervention for MV dysfunction	0
BARC 2, 3, or 5 bleeding	1 (20)
Bioprosthetic valve dysfunction
Embolization	0
Thrombosis	0
Erosion, migration	0
Echocardiographic outcomes	(n = 5)*
Left ventricular ejection fraction (%)	55
Mean mitral gradient (mm Hg)	5.3 (4.5–6.5)
Central MR grade 0	5
PVL (moderate)	2

Values are n, n (%), or median (range).

^*One patient’s 30-day echocardiographic study was completed to discharge.

BARC = Bleeding Academic Research Consortium; MR = mitral regurgitation; MV = mitral valve; PVL = paravalvular leak; TIA = transient ischemic attack.